|
2024
|
Invention
|
Bacteriophage compositions for treating pseudomonas infections.
The present disclosure relates t... |
|
|
Invention
|
Bacteriophage compositions for treating staphylococcus infection.
The present disclosure relates... |
|
|
Invention
|
Bacteriophage compositions for treating pseudomonas infection.
The present disclosure relates to... |
|
2023
|
Invention
|
Staphylococcus infection. Staphylococcus aureus bacterial infections. |
|
2022
|
Invention
|
Therapeutic bacteriophage compositions.
The present invention relates to a bacteriophage composi... |
|
|
Invention
|
Bacteriophages with improved antimicrobial activity.
Provided herein are bacteriophages engineer... |
|
|
Invention
|
Bacteriophages with improved antimicrobial activity. Provided herein are bacteriophages engineere... |
|
2021
|
Invention
|
Pseudomonas infection. PseudomonasPseudomonasPseudomonasaeruginosaaeruginosa, bacterial infections. |
|
|
Invention
|
Staphylococcus infection. StaphylococcusStaphylococcusStaphylococcusStaphylococcus aureus, bacter... |
|
2019
|
Invention
|
Therapeutic bacteriophage compositions. The present invention relates to a bacteriophage composit... |
|
|
Invention
|
Bacteriophage treatment and reduction in inflammatory response. The present invention relates to ... |
|
|
Invention
|
B. fragilis infections. The present invention relates to a bacteriophage composition comprising o... |
|
|
Invention
|
Bacteriophage for treatment and prevention of bacteria-associated cancers. The present invention ... |
|
|
P/S
|
Targeted, pathogen-specific antimicrobial pharmaceutical preparations for the treatment of bacter... |
|
|
P/S
|
Custom manufacturing of medicines and pharmaceuticals Research and development in the fields of m... |
|
2012
|
Invention
|
Bacteriophages. Staphylococcus strains and in particular MRSA. There is also provided a pharmaceu... |
